CONMED Corporation
CNMD
$34.49
-$0.29-0.82%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.37B | 1.37B | 1.35B | 1.33B | 1.32B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.37B | 1.37B | 1.35B | 1.33B | 1.32B |
| Cost of Revenue | 629.64M | 634.25M | 586.44M | 575.74M | 575.18M |
| Gross Profit | 740.87M | 740.48M | 761.04M | 750.51M | 740.82M |
| SG&A Expenses | 559.71M | 556.12M | 553.15M | 540.93M | 534.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.25B | 1.25B | 1.19B | 1.17B | 1.16B |
| Operating Income | 121.89M | 128.47M | 153.72M | 155.76M | 152.73M |
| Income Before Tax | 81.80M | 71.12M | 85.51M | 137.69M | 145.28M |
| Income Tax Expenses | 26.95M | 24.06M | 21.44M | 27.49M | 26.53M |
| Earnings from Continuing Operations | 54.85 | 47.06 | 64.07 | 110.20 | 118.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.85M | 47.06M | 64.07M | 110.20M | 118.75M |
| EBIT | 121.89M | 128.47M | 153.72M | 155.76M | 152.73M |
| EBITDA | 195.56M | 201.55M | 225.76M | 227.16M | 223.40M |
| EPS Basic | 1.78 | 1.52 | 2.07 | 3.57 | 3.85 |
| Normalized Basic EPS | 1.84 | 1.95 | 2.44 | 2.45 | 2.36 |
| EPS Diluted | 1.77 | 1.51 | 2.05 | 3.53 | 3.80 |
| Normalized Diluted EPS | 1.84 | 1.94 | 2.43 | 2.43 | 2.34 |
| Average Basic Shares Outstanding | 123.46M | 123.85M | 123.80M | 123.70M | 123.57M |
| Average Diluted Shares Outstanding | 123.76M | 124.29M | 124.40M | 124.46M | 124.52M |
| Dividend Per Share | 0.40 | 0.60 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 33.85% | 52.59% | 38.60% | 22.42% | 20.78% |